Is generative pre-trained transformer artificial intelligence (Chat-GPT) a reliable tool for guidelines synthesis? A preliminary evaluation for biologic CRSwNP therapy.
Antonino ManiaciAlberto Maria SaibeneChristian Calvo-HenriquezLuigi VairaThomas RadulescoJustin MichelCarlos Chiesa-EstombaLeigh SowerbyDavid Lobo DuroMiguel Mayo-YanezJuan Maza-SolanoJerome Rene LechienIgnazio La MantiaSalvatore CocuzzaPublished in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2024)
Biologic therapies have surfaced as a promising treatment option for patients with severe or refractory CRSwNP; however, the optimal patient population, dosage, and treatment duration are yet to be defined. The application of AI in decision-making protocols and the creation of therapeutic algorithms for biologic drug selection, could offer fascinating future prospects in the management of CRSwNP.